Ultime prove

EudraCT Number: 2017-005129-18

Sponsor Protocol Number: PROMISE

Start Date:

Sponsor Name: Università degli Studi Aldo Moro

Full Title: Multi-centre, randomised, open label pragmatic trial to compare the effectiveness and safety of interferon beta-1a (IFN-beta-1a) weekly i.m. and glatiramer-acetate (GA) in paediatric patients affec...

Medical condition: Relapsing-remitting multiple sclerosis with paediatric onset

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10029205 - Nervous system disorders	10028245	Multiple sclerosis	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-022273-34

Sponsor Protocol Number: CRAD001KDE37

Start Date:

Sponsor Name: Novartis Pharma GmbH

Full Title: A multi-centric, open-label, phase II study investigating the combination of Afinitor with paclitaxel and carboplatin in first line treatment of patients with advanced (stage IV) large cell lung c...

Medical condition: large-cell neuroendocrine carcinoma of the lung

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10057270	Neuroendocrine carcinoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2009-013792-22

Sponsor Protocol Number: LEO 29102-C21

Start Date:

Sponsor Name: LEO Pharma A/S

Full Title: A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pim...

Medical condition: Diagnosis of atopic dermatitis graded as mild to moderate according to the Rajka and Langeland system.

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10003639	Atopic dermatitis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) FI (Completed)

Trial results: View results

EudraCT Number: 2011-004878-29

Sponsor Protocol Number: NA

Start Date:

Sponsor Name: St. Antonius Hospital

Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis

Medical condition: Acute calculous cholecystitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10019805 - Hepatobiliary disorders	10008612	Cholecystitis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-021134-66

Sponsor Protocol Number: IJL-AFHT-TH10

Start Date:

Sponsor Name: Institut Jerome Lejeune

Full Title: Efficacy assessment of systematic treatment with folinic acid and thyroid hormone on psychomotor development of Down Syndrome young children

Medical condition: Down syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10010331 - Congenital, familial and genetic disorders	10044688	Trisomy 21	PT
	14.0	10010331 - Congenital, familial and genetic disorders	10013616	Down's syndrome	LLT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2019-001866-14

Sponsor Protocol Number: 3150-303-008

Start Date:

Sponsor Name: AstraZeneca AB

Full Title: An Open-label, Long-term Extension Study of Brazikumab in Participants with Moderately to Severely Active Crohn’s Disease

Medical condition: Moderately to Severely Active Crohn’s Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004856	10011402	Crohn's disease (colon)	LLT

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) DE (Completed) CZ (Prematurely Ended) AT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) IT (Ongoing) FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2020-002255-37

Sponsor Protocol Number: MGT-RPGR-022

Start Date:

Sponsor Name: MeiraGTx UK II Limited

Full Title: Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene

Medical condition: X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10010331 - Congenital, familial and genetic disorders	10038914	Retinitis pigmentosa	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-004966-34

Sponsor Protocol Number: 38825

Start Date:

Sponsor Name: NV Organon

Full Title: A phase III, uncontrolled trial to assess the non-immunogenicity and safety of Org 36286 in patients undergoing repeated controlled ovarian stimulation cycles using a multiple dose GnRH antagonist ...

Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10017399		LLT

Population Age: Adults

Gender: Female

Trial protocol: DE (Completed) DK (Completed) SE (Completed) HU (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-003816-47

Sponsor Protocol Number: Met-ADI-01

Start Date:

Sponsor Name: Pädiatrische Endokrinologie, Universitätsmedizin Berlin, Charité

Full Title: Clinical pilot study on the effect of Metformin in adipose children and adolescents with insulin-resistance Klinische Pilotstudie zur Untersuchung der Wirkung von Metformin bei adipösen Kindern un...

Medical condition: Insuline-resistance in adipose children and adolescents

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2010-021139-15

Sponsor Protocol Number: ESC-928-MOL-0000-I

Start Date:

Sponsor Name: Technische Universität München Fakultät für Medizin

Full Title: Do Selective Radiation Dose Escalation and Tumor Hypoxia Status Impact the Locoregional Tumor Control after Radiochemotherapy of Head & Neck Tumors?

Medical condition: This study tests the hypothesis that the Radiation dose escalation to the macroscopic Tumor improves the locoregional control survival after concomitant chemoradiation over 2 years. As a transla...

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10067821	Head and neck cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

Ultime prove

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici